Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Author: Clinical Editor

Improving maternity services: we must move away from unhelpful labels

Titcombe calls for acknowledgment that normal childbirth is being pursued at the expense of safety and notes that […]

September 15, 2026 Uncategorized

The MSRA is a one-size-fits-all approach to specialty job selection

The multi-specialty recruitment assessment (MSRA) is widely used to shortlist doctors in the UK for specialty training. This […]

September 15, 2026 Uncategorized

Study highlights advance in influenza protection for older adults

Study highlights advance in influenza protection for older adults
p p Read More

Phase 3 data supports combined vaccine technologies

September 15, 2026 News

NICE backs daratumumab quadruplet for transplant‑eligible myeloma

NICE backs daratumumab quadruplet for transplant‑eligible myeloma
p p Read More

Guidance supports MRD‑guided treatment approach

September 15, 2026 News

Heatwaves: Life threatening emergencies peak as NHS cancels 1000 operations

Four NHS ambulance trusts in England recorded their highest ever number of life threatening emergencies during this summer’s […]

September 15, 2026 Uncategorized

School meals: Ministers ban deep fried foods as they dish up new standards

Pizza, hot dogs, muffins, and ice cream will all be restricted in school meals as part of new […]

September 15, 2026 Uncategorized

Trump’s “dismantling” of NIH research continues apace

When Donald Trump returned to the US presidency in January 2025, many biomedical researchers were uneasy about the […]

September 14, 2026 Uncategorized

Scientists find a hidden cause of high blood pressure that routine tests can miss

A wearable device has revealed nighttime hormone surges that may expose a frequently missed cause of high blood […]

September 14, 2026 Uncategorized

Teitur reports positive early data for Parkinson’s peptide TT‑P34

Teitur reports positive early data for Parkinson’s peptide TT‑P34
p p Read More

Phase 1 trial shows strong safety and CNS exposure

September 14, 2026 News

Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer

Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer
p p Read More

New data shows nearly three‑year median overall survival

September 14, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 2,040 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy